Dr. Jeffrey Almond began his career as an academic virologist studying influenza. Eventually Jeffrey started his own lab and began studying picornaviruses working on an oral polio vaccine strain.
Following twenty years in academics including major contributions in the eradication of polio worldwide, Jeffrey transitioned into a career in industry working on vaccine development at Sanofi Pasteur.
In March of 2013, Jeffrey was at the Society for General Microbiology's Spring conference to give the Colworth Prize Lecture awarded biennially for an outstanding contribution in an area of applied microbiology. Jeffrey's talk was titled: Vaccines R&D;: challenges for the 21st century.
On this episode, Vincent Racaniello talks with Dr. Almond about the future of vaccines, his transition from academia to industry and his prize lecture.

MWV76 - Jeffrey Almond - Vaccine Development

A video podcast by the American Society for Microbiology that highlights the latest in microbiology, life science and biotechnology news. ASM is composed of over 42,000 scientists and health professionals with the mission to advance the microbial sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide. For information about ASM and MicrobeWorld, visit us online at www.microbeworld.org.

Science & Medicine

Natural Sciences

Social Sciences

Medicine

Education

Training

Language Courses

Higher Education

K-12

Educational Technology

The most common analogy for CRISPR systems is that of molecular scissors. Joe Bondy-Denomy offers an alternative analogy from the bacteriophage perspective, all based on scientific data. 

CRISPR from a Bacteriophage Perspective

We may not see microplastics, but they are all around us. These microplastics play a role in shaping the microbial environment, and this talk will explain how. 

Microplastics in the Water and their Interaction with Microbes

Science communication experts discuss creative ways (like variations of escape-the-room, the Up-Goer Five Challenge, or edible learning aids) to get people to interact with science. Jennifer Gardy, Kathryn (KT) Elliott, and Dave Westenberg discuss the inspiration for their creative approaches and tips for other who want to improve their scicomm skills. 

New Engaging Approaches for Science Communication

CDC Principal Deputy Director Anne Schuchat has extensive experience in global health and science advocacy. Jennifer Gardy interviews Schuchat about emerging disease threats and what advice for early-career scientists Schuchat can offer. Schuchat talks about translating disease detective work into policies that decrease infection rates, citing the successes in decreasing group B Streptococcus infections, developing group A meningococcal vaccines, and halting the recent West African Ebola outbreak. Schuchat talks about her road from an Emerging Infectious Disease fellow to her role in preparing for emerging disease as Deputy Director, and her vision for a future of interdisciplinary collaboration for the greater benefit of global public health. 

Disease Detective - Anne Schuchat - Principal Deputy Director of CDC

From ASM Microbe 2017 at New Orleans, Vincent and Rich meet up with Kate Rubins to talk about becoming an astronaut, space travel, and doing science in space. Hosts: Vincent Racaniello and Rich Condit Guest: Kate Rubins Thumbnail Photo by Chris Condayan Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

MWV76 - Jeffrey Almond - Vaccine Development

Download our free app to listen on your phone